Sichuan Kelun Pharmaceutical Co (SZSE:002422) 3-Year EBITDA Growth Rate : 21.70% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co 3-Year EBITDA Growth Rate?

Sichuan Kelun Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥1.09.

During the past 12 months, Sichuan Kelun Pharmaceutical Co's average EBITDA Per Share Growth Rate was 28.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sichuan Kelun Pharmaceutical Co was 29.60% per year. The lowest was -1.80% per year. And the median was 15.75% per year.

Competitive Comparison of Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Sichuan Kelun Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Sichuan Kelun Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071

Website

http://www.kelun.com

Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.

Executives

Lai De Gui	Executives
Feng Hao	Directors, executives
Liu Si Chuan	Directors, executives
Wang Jing Yi	Directors, executives
Wan Yang Yu	Executives
Ge Jun You	Executives
Wu Zhong Hua	Executives
Wan Peng	Supervisors
Tan Hong Bo	Executives
Liu Ge Xin	Director
Huang Xin	Securities Affairs Representative
Ge Tao	Executives
Pan Hui	Directors, executives
Zhou Xiao Dong	Executives
Zheng Chang Yan	Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines